Ketogenic diet guidelines for infants with refractory epilepsy.

Area of Science:

• Pediatric Neurology
• Metabolic Therapies
• Clinical Nutrition

Background:

• The ketogenic diet (KD) is a proven non-pharmacologic treatment for drug-resistant childhood epilepsy.
• Historically contraindicated in infants due to developmental concerns and nutritional risks, recent evidence shows KD is effective and well-tolerated in this age group.
• Infants have unique nutritional needs, necessitating standardized protocols for KD implementation.

Purpose of the Study:

• To establish a consensus statement on the clinical management of the ketogenic diet in infants with epilepsy.
• To provide standardized recommendations for the safe and effective use of KD in this vulnerable population.

Main Methods:

• A project group of 5 experts developed consensus recommendations for KD management in infants.
• The draft manuscript was reviewed and amended by 10 additional international experts in the KD field.
• Consensus was achieved on diet administration and patient selection criteria.

Main Results:

• Developed comprehensive recommendations covering patient selection, pre-diet counseling, and nutritional requirements.
• Provided guidance on diet initiation, monitoring for adverse effects during initiation and follow-up, and discontinuation criteria.
• Recommendations address the specific needs of infants undergoing KD therapy.

Conclusions:

• The consensus statement offers evidence-based recommendations and expert opinions for clinical KD use in infants.
• Highlights the need for standardized protocols to optimize KD therapy for infants with epilepsy.
• Identifies directions for future research in infant ketogenic diet therapy.